Runxiang Yang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
Papers in
- Oncology 22
- Lung Cancer Research Studies 14
- Peptidase Inhibition and Analysis 5
- Cancer Cells and Metastasis 3
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Lijuan Zhang (1 shared paper)Hongmei Shen (1 shared paper)Guangqiang Zhao (1 shared paper)Yunchao Huang (1 shared paper)Lincan Duan (1 shared paper)Xinyi Cai (1 shared paper)Ceshi Chen (4 shared papers)Zhongmei Zhou (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Thoracic Oncology (2 papers)Annals of Oncology (2 papers)Frontiers in Immunology (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Runxiang Yang
32 papers receiving 376 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 79
- Oncology 140
- Molecular Biology 154
- Pulmonary and Respiratory Medicine 60
- Epidemiology 46
Countries citing papers authored by Runxiang Yang
This map shows the geographic impact of Runxiang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runxiang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runxiang Yang more than expected).
Fields of papers citing papers by Runxiang Yang
This network shows the impact of papers produced by Runxiang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runxiang Yang. The network helps show where Runxiang Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Runxiang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2023 | 59 | |
| 3 | 2018 | 31 | |
| 4 | 2013 | 25 | |
| 5 | 2017 | 18 | |
| 6 | 2023 | 16 | |
| 7 | 2024 | 16 | |
| 8 | Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway. | 2020 | 15 |
| 9 | 2023 | 14 | |
| 10 | 2018 | 14 | |
| 11 | 2025 | 13 | |
| 12 | 2021 | 10 | |
| 13 | 2024 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2025 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2025 | 3 |
About Runxiang Yang
Runxiang Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Cancer Research, having authored 34 papers that have together received 380 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer therapeutics and mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cancer Research (79 citations), Oncology (140 citations), Molecular Biology (154 citations), Pulmonary and Respiratory Medicine (60 citations) and Epidemiology (46 citations). Runxiang Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lijuan Zhang, Hongmei Shen, Guangqiang Zhao, Yunchao Huang, Lincan Duan, Xinyi Cai, Ceshi Chen, Zhongmei Zhou, Rong Liu and Tianning Zou. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Frontiers in Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.